Improving CSF Biomarkersâ€™ Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimerâ€™s Disease by Considering Different Confounding Factors: A Meta-Analysis-Reference-Cited by-同舟云学术

Improving CSF Biomarkersâ€™ Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimerâ€™s Disease by Considering Different Confounding Factors: A Meta-Analysis

Published:2014-10-16 Issue: Volume:6 Page:
ISSN:1663-4365
Container-title:Frontiers in Aging Neuroscience
language:
Short-container-title:Front. Aging Neurosci.

Author:

Ferreira Daniel,Rivero-Santana Amado,Perestelo-PÃ©rez Lilisbeth,Westman Eric,Wahlund Lars-Olof,SarrÃa Antonio,Serrano-Aguilar Pedro

Publisher

Frontiers Media SA

Subject

Cognitive Neuroscience,Aging

Reference63 articles.

1. The diagnosis of mild cognitive impairment due to Alzheimerâ€™s disease: recommendations from the National Institute on Aging-Alzheimerâ€™s Association workgroups on diagnostic guidelines for Alzheimerâ€™s disease;Albert;Alzheimers Dement.,2011

2. CSF biomarkers for Alzheimerâ€™s disease diagnosis;Anoop;Int. J. Alzheimers Dis.,2010

3. Revised criteria for mild cognitive impairment: validation within a longitudinal population study;Artero;Dement. Geriatr. Cogn. Disord.,2006

4. Neuropathology of older persons without cognitive impairment from two community-based studies;Bennett;Neurology,2006

5. Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimerâ€™s disease;Bloudek;JAD,2011

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer’s disease: racial differences;Neurological Sciences;2023-09-28

2. Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO;Molecular Neurodegeneration;2023-07-29

3. Estudio CORCOBIA: determinación de puntos de corte de biomarcadores de enfermedad de Alzheimer en LCR en una cohorte clínica;Neurología;2022-09

4. The CORCOBIA study: Cut-off points of Alzheimer’s disease CSF biomarkers in a clinical cohort;Neurología (English Edition);2022-08

5. The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer’s Disease Risks;Journal of Alzheimer's Disease;2022-06-14